MARKET

SCTL

SCTL

SOCIETAL CDMO INC
NASDAQ
1.680
+0.100
+6.33%
Opening 12:28 10/04 EDT
OPEN
1.580
PREV CLOSE
1.580
HIGH
1.680
LOW
1.550
VOLUME
30.07K
TURNOVER
36.88K
52 WEEK HIGH
2.190
52 WEEK LOW
0.6200
MARKET CAP
95.19M
P/E (TTM)
-6.7443
1D
5D
1M
3M
1Y
5Y
Societal CDMO Announces Signing of Multiple Agreements With New and Existing Customers
Company Further Diversifies Customer Base with New Clients, Expands Scope of Work with Current CustomersSAN DIEGO and GAINESVILLE, Ga., Sept. 29, 2022 (GLOBE NEWSWIRE) -- Societal CDMO, Inc. (“Societal CDMO”; NASD: SCTL), a contract development and manufac...
GlobeNewswire · 5d ago
SCTL: New contracts support high-touch customer strategy
By Beth Senko, CFA NASDAQ:SCTL READ THE FULL SCTL RESEARCH REPORT Societal CDMO’s (NASDAQ:SCTL) high-touch customer strategy continues to gain steam. In early September, Societal announced two new contracts. The first contract supports development of novel...
Zacks Small Cap Research · 09/16 12:06
BRIEF-Societal CDMO Appoints Elena Cant To Board Of Directors
BRIEF-Societal CDMO Appoints Elena Cant To Board Of Directors
Reuters · 09/08 12:38
Societal stock soars 20% on signing 2 manufacturing contracts
Societal CDMO (NASDAQ:SCTL) <a href="https://seekingalpha.com...
Seekingalpha · 09/07 12:24
BRIEF-Societal Cdmo Awarded Two New Cdmo Service Contracts Focused On Supporting Ongoing Clinical Development Programs For Novel Therapeutic Candidates
BRIEF-Societal Cdmo Awarded Two New Cdmo Service Contracts Focused On Supporting Ongoing Clinical Development Programs For Novel Therapeutic Candidates
Reuters · 09/07 11:20
Societal CDMO Wins Two Service Contracts for Clinical Development Programs
Societal CDMO Wins Two Service Contracts for Clinical Development Programs
MT Newswires · 09/07 08:24
BRIEF-Societal CDMO - On Aug 18, Received Letter From Nasdaq Confirming Co Regained Compliance With Nasdaq’S Minimum Bid Price Continuing Listing Requirement
BRIEF-Societal CDMO - On Aug 18, Received Letter From Nasdaq Confirming Co Regained Compliance With Nasdaq’S Minimum Bid Price Continuing Listing Requirement
Reuters · 08/22 20:41
SCTL: Reaping benefits from realignment
By Beth Senko, CFA NASDAQ:SCTL READ THE FULL SCTL RESEARCH REPORT On August 16, Societal CDMO announced it has taken the first step to reduce its debt, with the pending sale of 121 acres of lakefront land to a developer for ~$9.1 million. Subject to due di...
Zacks Small Cap Research · 08/17 11:56
More
About SCTL
Societal CDMO, Inc. is a bi-coastal contract development and manufacturing organization (CDMO). The Company is engaged in spanning pre-investigational new drug development to commercial manufacturing and packaging for a range of therapeutic dosage forms with a primary focus on the area of small molecules. It is involved in CDMO providing therapeutic development, end-to-end regulatory support, clinical and commercial manufacturing, aseptic fill/finish, lyophilization, packaging and logistics services to the global pharmaceutical market. Its key products include Ritalin LA, Focalin XR, Verelan PM, Verelan SR, Verapamil PM, Verapamil SR, Donnatal liquids and tablets and Scot-Tussin cough and cold liquids. Its manufacturing and development capabilities include formulation, product development from formulation through clinical trial and commercial manufacturing, and specialized capabilities for solid oral dosage forms, extended-release and controlled substance manufacturing.

Webull offers kinds of Societal CDMO Inc stock information, including NASDAQ:SCTL real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SCTL stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading SCTL stock methods without spending real money on the virtual paper trading platform.